PMC:7073332 / 761-1004
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
47 | 27-32 | Species | denotes | human | Tax:9606 |
48 | 129-138 | Species | denotes | 2019-nCoV | Tax:2697049 |
49 | 139-149 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
50 | 203-211 | Species | denotes | SARS-CoV | Tax:694009 |
60 | 98-102 | Species | denotes | HCoV | Tax:694448 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 33-40 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T2 | 41-48 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T3 | 109-116 | Body_part | denotes | genomes | http://purl.org/sig/ont/fma/fma84116 |
T4 | 169-179 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T6 | 139-147 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 203-211 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 27-40 | http://purl.obolibrary.org/obo/PR_000029067 | denotes | human protein |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 7-11 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T11 | 33-40 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T12 | 41-48 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T13 | 169-179 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 70-220 | Sentence | denotes | Phylogenetic analyses of 15 HCoV whole genomes reveal that 2019-nCoV/SARS-CoV-2 shares the highest nucleotide sequence identity with SARS-CoV (79.7%). |